This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Company Filing History:
1 out of 834,307 Years Active: 2001
Title: The Innovations of William A. Hagopian
Introduction
William A. Hagopian is a notable inventor based in Seattle, Washington. He has made significant contributions to the field of medical science, particularly in the area of diabetes research. His work focuses on the development of innovative solutions for insulin-dependent diabetes mellitus (IDDM).
Latest Patents
Hagopian holds a patent for Islet Cell Antigen 1851. This patent discloses a mammalian islet cell antigen polypeptide that plays a crucial role in the development of IDDM. The polypeptide, 1851, has been found to contain regions of homology to the protein tyrosine phosphatase family. The patent also presents methods for diagnosis and treatment, including the use of immunoprecipitation assays and the induction of immune tolerance through recombinant mammalian polypeptides and antibodies specific to the islet cell antigen 1851.
Career Highlights
Throughout his career, William A. Hagopian has demonstrated a commitment to advancing medical research. His innovative approach has led to breakthroughs that could improve the lives of those affected by diabetes. His work is characterized by a strong focus on practical applications of scientific discoveries.
Collaborations
Hagopian has collaborated with esteemed colleagues such as Wayne R. Kindsvogel and Laura J. Jelinek. These partnerships have fostered a collaborative environment that enhances the research and development of new medical technologies.
Conclusion
William A. Hagopian's contributions to diabetes research through his patent on Islet Cell Antigen 1851 exemplify the impact of innovation in medical science. His work continues to inspire advancements that may lead to better treatment options for individuals with insulin-dependent diabetes mellitus.